U.S. Patent Litigations
PACER
Case No(s):
U.S. Patent Nos.
8,697,443 (Cell Culture Methods and Devices Utilizing Gas Permeable Materials) 9,441,192 (Cell Culture Methods and Devices Utilizing Gas Permeable Materials)
Plaintiffs
Wilson Wolf Manufacturing Corporation
Defendants
Sarepta Therapeutics, Inc.
Status
Stayed
BPCIA
N
U.S. Patent Nos.
10,526,617 (Method of Detecting and/or Identifying Adeno-Associated Virus (AAV) Sequences and Isolating Novel Sequences Identified Thereby)
Plaintiffs
REGENXBIO Inc.; Trustees of the University of Pennsylvania
Defendants
Sarepta Therapeutics, Inc.; Sarepta Therapeutics Three, LLC; Catalent, Inc.
Federal Circuit Appeal(s)
24-1408
Status
Summary Judgment: Patent Invalid- Ineligible Subject Matter under Section 101; Federal Circuit Appeal Pending
BPCIA
N
U.S. Patent Nos.
11,680,274 (Method of Increasing the Function of an AAV Vector)
Plaintiffs
REGENXBIO Inc.; Trustees of the University of Pennsylvania
Defendants
Sarepta Therapeutics, Inc.; Sarepta Therapeutics Three, LLC; Catalent, Inc.
Status
Stayed Pending IPR2024-00580
BPCIA
N
U.S. Patent Nos.
7,704,721 (Compositions and Methods to Prevent AAV Vector Aggregation) 9,051,542 (Compositions and Methods to Prevent AAV Vector Aggregation)
Plaintiffs
Genzyme Corporation
Defendants
Sarepta Therapeutics, Inc.; Sarepta Therapeutics Three, LLC
Status
Case Ongoing
BPCIA
N